Information regarding the novel coronavirus is rapidly evolving as scientists and public-health officials race to uncover important details on the spread and cure of the virus, which as of Monday, February 3rd has affected residents in 25 countries around the globe.
February 4, 2020
What do we know about the novel coronavirus, 2019-nCoV?
February 2, 2020 / Reuters
Thailand sees an apparent success in treating the novel coronavirus with a drug cocktail comprised of anti-flu and anti-virals used to treat HIV.
February 2, 2020 / The New York Times
Experts say that the novel coronavirus looks increasingly like a pandemic (an epidemic spread across two continents). Scientists, however, are uncertain as to how lethal the new coronavirus may be.
January 29, 2020 / Doherty Institute
Scientists from Melborne’s Doherty Institute are the first to grow the novel coronavirus from a patient sample, which may allow accurate investigation and diagnosis of the virus globally. This is the first time the virus has been grown in cell culture outside of China.
PharPoint Research: Infectious Disease experience
PharPoint’s biostatistics and data management teams hold extensive experience participating in infectious disease clinical trials from Phase 1 to 4, including numerous study rescues.
We’ve participated in studies for infectious disease indications including HIV-1 and Influenza, among others.
PharPoint’s biostatistics team has participated in 230+ infectious disease studies as of February 2020. For more information on our biostatistics, data management, and clinical operations services, reach out to a PharPoint representative.